Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 81.26%-1.63K | -1,906.08%-39.48K | 581.48%50.13K | 81.16%-53.75K | -99.79%-36.83K | 83.84%-8.69K | 102.32%2.19K | 91.24%-10.41K | 84.18%-285.32K | 90.78%-18.44K |
| Net income from continuing operations | 67.78%-41.69K | 28.49%-74.27K | -58.52%24.03K | 69.70%-225.75K | 38.85%-50.41K | -27.08%-129.4K | 57.09%-103.86K | 118.17%57.92K | 67.11%-744.99K | 57.63%-82.43K |
| Operating gains losses | ---- | ---- | ---- | ---55K | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | --0 | --0 | 0.00%4.36K | 0.00%17.45K | 0.02%4.36K | -0.02%4.36K | 0.00%4.36K | 0.00%4.36K | 71.43%17.45K | -57.14%4.36K |
| Unrealized gains and losses of investment securities | --0 | ---- | ---- | ---- | ---- | --10K | ---- | ---- | ---- | ---- |
| Other non cashItems | --0 | 1,876.80%48.06K | 52.70%-46.09K | -112.84%-16.89K | 558.52%75.83K | --2.29K | --2.43K | -181.20%-97.43K | 119.10%131.52K | --11.52K |
| Change In working capital | -61.50%40.06K | -11.39%34.79K | -20.07%19.77K | -27.12%226.44K | 21.34%58.38K | 138.22%104.06K | -72.62%39.26K | -67.24%24.74K | -20.52%310.7K | 163.68%48.12K |
| -Change in receivables | 106.91%700 | 417.68%28.32K | -586.85%-28.68K | -54.59%7.48K | 74.75%16.32K | -23,136.36%-10.14K | -39.06%5.47K | -120.55%-4.18K | -92.41%16.47K | 559.39%9.34K |
| -Change in prepaid assets | -326.07%-3.22K | 137.84%1.21K | 7.35%1.2K | -96.88%4.27K | -81.33%1.23K | 133.12%1.42K | -99.50%510 | -96.61%1.12K | -31.63%137K | 203.70%6.56K |
| -Change in payables and accrued expense | -62.24%42.58K | -84.22%5.25K | 69.98%47.25K | 36.54%214.69K | 26.78%40.84K | 135.27%112.78K | 2.22%33.27K | -37.58%27.8K | 699.18%157.24K | 145.60%32.22K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 81.26%-1.63K | 292.27%8.58K | 119.94%2.08K | 81.16%-53.75K | -99.79%-36.83K | 83.84%-8.69K | 102.32%2.19K | 91.24%-10.41K | 84.18%-285.32K | 90.78%-18.44K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -91.86%25K | 25K | 0 | 0 | 0 | -31.02%307.31K | 0 | |||
| Net PPE purchase and sale | ---- | ---- | ---- | --25K | ---- | ---- | ---- | ---- | ---- | ---- |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | -31.02%307.31K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | -91.86%25K | --25K | --0 | --0 | --0 | -31.02%307.31K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | -66.59%-10.35K | -3.34%-6.35K | -91.09%-6.35K | -102.64%-6.21K | -112.74%-6.14K | -104.35%-24.24K | 78.13%-14.96K | ||
| Net issuance payments of debt | --0 | 100.03%2 | -3.34%-6.35K | ---- | ---- | -91.09%-6.35K | -102.64%-6.21K | -112.74%-6.14K | -74.86%-24.24K | 7.21%-14.96K |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Net other financing activities | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | -66.59%-10.35K | -3.34%-6.35K | ---- | ---- | -91.09%-6.35K | -102.64%-6.21K | -112.74%-6.14K | -104.35%-24.24K | 78.13%-14.96K |
| Net cash flow | ||||||||||
| Beginning cash position | -81.43%3.24K | -76.65%5.02K | -75.58%9.29K | -5.58%38.04K | -96.62%2.42K | 383.84%17.45K | -16.64%21.48K | -5.58%38.04K | -95.21%40.28K | -77.05%71.43K |
| Current changes in cash | 89.17%-1.63K | 55.92%-1.78K | 74.19%-4.27K | -1,178.78%-28.75K | 120.58%6.87K | -122.17%-15.04K | 81.83%-4.03K | -14.06%-16.56K | 99.72%-2.25K | 87.68%-33.4K |
| End cash Position | -33.28%1.61K | -81.43%3.24K | -76.65%5.02K | -75.58%9.29K | -75.58%9.29K | -96.62%2.42K | 383.84%17.45K | -16.64%21.48K | -5.58%38.04K | -5.58%38.04K |
| Free cash from | 81.26%-1.63K | 292.27%8.58K | 119.94%2.08K | 81.16%-53.75K | -99.79%-36.83K | 83.84%-8.69K | 102.32%2.19K | 91.24%-10.41K | 84.18%-285.32K | 90.78%-18.44K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.